AI study of patient records reveals possible new side effects of common blood pressure medications
Researchers used artificial intelligence to analyze millions of patient records, uncovering previously unrecognized side effects.
Researchers used artificial intelligence to analyze millions of patient records, uncovering previously unrecognized side effects.
Editor's note: IBS affects 1 in 10 people globally. The following articles cover the latest clinical evidence on gut-brain research, reviewed by gastroenterologists and published researchers. All content cites peer-reviewed sources.
We tracked FODMAP, antispasmodics, probiotics, antidepressants, and gut-directed hypnotherapy over 4 months. All helped at first. Only one delivered lasting relief with zero side effects.
Dr. Joanne Holt, gastroenterologist with 20+ years of clinical experience, explains why elimination diets only reduce flares while leaving the underlying gut-brain dysfunction untouched, and what the clinical evidence says actually resolves it.
For years, no one could explain why the IBS gut stays reactive even between flares, even on good days. Gut-brain researchers studying a specific nerve pathway may have found the answer.
70% of patients saw lasting relief. Results held at 12 months. The British Society of Gastroenterology has recommended it since 2021. Fewer than 5% of patients are ever offered it.
Most IBS treatments are studied over 6 to 8 weeks, which is when they look their best. Prof. Magnus Simren wanted to know what happens a year later. One treatment stood clearly apart.
Most had tried three or more treatments. Most said the same thing about each one: it helped at first, then stopped. But one treatment appeared at the top with striking consistency. 72% had never been told about it by their doctor.
James Kingsland
· 5 minCorrie Pelc
· 4 minDr. Emily Torres
· 6 minMichael Chen
· 4 minDr. Lisa Hernandez
· 5 minFree Newsletter
Join 12M+ readers. No junk science. Unsubscribe any time.